Last updated: June 4, 2026
ZITUVIO suppliers: Who manufactures, packages, and supplies ZITUVIO (site, labeler, and supply-chain mapping)
ZITUVIO is listed as a branded pharmaceutical product, but “ZITUVIO” does not uniquely resolve to a specific FDA NDC-labeled product record in the information available in this chat context. Without a verifiable drug identity (active ingredient, dosage form, strength, and FDA labeler/NDC), supplier and manufacturing responsibility cannot be mapped to named companies with defensible accuracy.
What company supplies ZITUVIO to pharmacies and wholesalers?
Featured answer: ZITUVIO’s supply-company identity cannot be determined from the provided information alone.
How do suppliers get assigned in US drug distribution (NDC labeler vs. manufacturer)?
A correct supplier mapping requires tying:
- The FDA NDC “labeler” (usually the applicant or marketing authorization holder in the US context)
- The “manufacturer” and “packager” fields (often different entities)
- The SPL product record for the specific strength and dosage form
- The US commercial distribution chain (wholesaler listings) tied to the NDC
None of these identifiers for ZITUVIO are present in the input.
Which manufacturers make the active ingredient and finished dosage form for ZITUVIO?
Featured answer: The active-ingredient supplier and finished-product contract manufacturing entities for ZITUVIO cannot be identified from the provided information alone.
APIs: what supplier data typically exists
For most branded drugs, API suppliers are not consistently disclosed publicly. When they are visible, it is usually through:
- FDA Drug Master File references and cross-linking to manufacturing statements
- Public contract manufacturing disclosures
- ANDA labeling paragraphs naming manufacturing sites
- Import/export registrations
- Periodic reports and inspection outcomes tied to facility names
No API identity or dosage form mapping for ZITUVIO is provided.
Finished dosage form: what supplier data typically exists
Finished-dose manufacturers and packagers show up in:
- FDA NDC directory fields
- SPL “manufacturer” and “packager” entries
- Establishment registrations (FDA FEI database)
- Consent decrees or inspection reports referencing facilities
No ZITUVIO NDC, FEI, strength, or dosage form is given.
What is the Orange Book status of ZITUVIO and how does that affect supplier selection?
Featured answer: Orange Book status cannot be determined without the specific FDA drug product record.
Why Orange Book matters for suppliers
The Orange Book ties:
- Patent owner and listed drug
- Dosage form and route
- Applicant/holder information that often aligns with labeler and marketing entity
That link is required to connect supplier questions to enforceable IP and regulatory status.
No Orange Book identifiers are supplied.
What packaging and labeling suppliers serve ZITUVIO?
Featured answer: Packaging and labeling suppliers cannot be identified without product-specific FDA labeler/NDC record information.
Packaging roles that change from product to product
In US commercialization, different entities can handle:
- Bottle/batch packaging operations
- Carton and label printing and serialization readiness
- Bundle kits or multipack assembly
- Temperature-controlled logistics packaging (if applicable)
No dosage form and strength are available for ZITUVIO in the prompt.
How do contract manufacturing and contract packaging suppliers differ for ZITUVIO?
Featured answer: The contract manufacturing vs. contract packaging split cannot be established without ZITUVIO’s FDA establishment-linked product record.
Typical split in the market
- Contract manufacturing organization (CMO) produces tablets/capsules/steriles at a registered facility
- Contract packaging organization (CPO) handles bottle filling, labeling, and cartonization
- Wholesalers distribute based on NDC-labeled supply
No facility or NDC linkage is provided.
What suppliers are involved if ZITUVIO is a biologic or infusion product?
Featured answer: ZITUVIO’s modality (small molecule vs. biologic) cannot be determined from the provided information.
Why modality changes the supplier map
Biologics can involve:
- Upstream drug substance manufacturing (DS)
- Drug product fill-finish
- Cold-chain packaging and distribution
- Specialized logistics vendors
No drug-type classification is provided.
Key Takeaways
- Supplier identification for “ZITUVIO” cannot be completed with the current input because ZITUVIO is not uniquely tied here to an FDA product record (active ingredient, strength, dosage form, NDC, and labeler fields).
- The correct supplier mapping requires product-specific FDA directory/Orange Book and establishment records, which are not present in the prompt.
FAQs
- What does the ZITUVIO NDC labeler field tell you about the supplier?
- Which FDA establishment (FEI) manufactures ZITUVIO drug product?
- Who provides ZITUVIO packaging, labeling, and unit-dose presentation?
- Does ZITUVIO use a contract manufacturing organization (CMO) or is it vertically integrated?
- How can I identify ZITUVIO’s supply chain from FDA SPL and wholesaler listings?
References (APA)
- U.S. Food and Drug Administration. Drugs@FDA.
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
- U.S. Food and Drug Administration. NDC Directory.
